News
Weight Loss, GLP-1 and Food and Drug Administration
Digest more
After questions and criticism online, Janelle Rohner says she should have disclosed her decision to take a GLP-1.
Newly recognized issues, including extreme fatigue with excessive weight reduction, bone loss, and abdominal pain, point to ...
After four years, those who took GLP-1 drugs had a 7% lower risk of developing an obesity-related cancer and an 8% lower risk ...
Dr. Rubinstein has years of experience working with patients to help them achieve their desired goals in a realistic, ...
14hon MSN
Manhattan-based dentist Dr. Sandip Sachar and obesity medicine specialist Dr. Meghan Garcia-Webb discuss the prevalence of ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results